Novavax
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Novavax generated cash of -$713,967,000, which is less than the previous year. Cash used in financing activities reached the amount of $4,466,000 last year. Net change in cash is therefore -$765,035,000.
Cash Flow
| 2014 | -67.01M | -129.83M | 109.71M |
|---|---|---|---|
| 2015 | -126.09M | -21.27M | 208.28M |
| 2016 | -255.46M | 28.01M | 279.03M |
| 2017 | -138.69M | 35.96M | 64.54M |
| 2018 | -184.82M | 28.59M | 102.80M |
| 2019 | -136.62M | 38.49M | 98.38M |
| 2020 | -42.54M | -377.77M | 984.76M |
| 2021 | 322.94M | 100.15M | 461.71M |
| 2022 | -415.93M | -92.98M | 324.98M |
| 2023 | -713.96M | -58.80M | 4.46M |
NVAX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.34B | 1.52B | 648.73M | 82.18M | 81.95M | 135.43M | 144.35M | 93.10M | 32.33M | 119.47M |
Operating activities | ||||||||||
Net income | -545.06M | -657.93M | -1.74B | -418.25M | -132.69M | -184.74M | -183.76M | -279.96M | -156.93M | -82.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 41.22M | 29.05M | 12.66M | 4.88M | 5.67M | 8.15M | 9.81M | 8.50M | 5.98M | 4.42M |
Stock-based compensation expense | 85.35M | 130.3M | 183.62M | 128.03M | 17.04M | 0 | 19.80M | 19.16M | 13.43M | 6.09M |
| Deferred income tax benefit | 85.35M | 130.3M | 183.62M | 128.03M | 17.04M | 0 | 19.80M | 19.16M | 13.43M | 6.09M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -274.44M | 249.16M | -192.26M | -422.68M | -4.20M | 1.21M | 0 | 2.07M | 6.25M | -5.70M |
Inventories | -74.45M | -477.80M | -600.32M | -163.16M | 4.20M | 0 | 0 | -1.97M | -8.04M | -4.01M |
Accounts payable | -378.80M | 913.39M | 600.32M | 163.16M | -11.48M | -6.74M | 5.19M | -4.80M | 9.07M | 13.97M |
Cash generated by operating activities | -713.96M | -415.93M | 322.94M | -42.54M | -136.62M | -184.82M | -138.69M | -255.46M | -126.09M | -67.01M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -2.16M | -363.20M | -17.48M | -120.15M | -218.04M | -356.55M | -228.52M | -176.46M |
Investments In Property Plant And Equipment | -58.80M | -92.98M | -57.48M | -54.62M | -1.85M | -1.37M | -4.18M | -18.21M | -18.28M | -7.26M |
Acquisitions Net | 0 | 0 | 57.48M | -165.51M | 18.33M | 1.37M | 4.18M | 18.21M | 18.28M | 7.26M |
Cash generated by investing activities | -58.80M | -92.98M | 100.15M | -377.77M | 38.49M | 28.59M | 35.96M | 28.01M | -21.27M | -129.83M |
Financing activities | ||||||||||
Common Stock Issued | 360.24M | 249.23M | 564.85M | 875.62M | 97.39M | 100.06M | 63.42M | 3.80M | 204.27M | 107.89M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -39.08M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -352.34M | 81.65M | -127.90M | -96.06M | 0 | 0 | -37K | -466K | -667K | -795K |
Cash used in financing activities | 4.46M | 324.98M | 461.71M | 984.76M | 98.38M | 102.80M | 64.54M | 279.03M | 208.28M | 109.71M |
Net Change In Cash | -765.03M | -179.41M | 879.52M | 566.55M | 221K | -53.47M | -38.04M | 51.24M | 60.77M | -87.13M |
Cash at end of period | 583.81M | 1.34B | 1.52B | 648.73M | 82.18M | 81.95M | 106.30M | 144.35M | 93.10M | 32.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |